AusPAR: Evolocumab
Australian Public Assessment Report
Device/Product Name
Repatha
Active ingredients
Evolocumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2017-02229-1-3
Submission Type
Extension of indications
Decision
Approved